What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- DNA
His main research concerns Cell biology, Sperm, Acrosome, Acrosome reaction and Molecular biology.
He combines subjects such as Membrane protein and Endocrinology, Spermatogenesis with his study of Cell biology.
His work deals with themes such as Lipid bilayer fusion, Green fluorescent protein and Human fertilization, which intersect with Sperm.
His Acrosome research is multidisciplinary, relying on both Golgi apparatus and Spermiogenesis, Nucleus.
His Acrosome reaction research focuses on Zona pellucida and how it connects with Exocytosis and Immunology.
His research integrates issues of Immunocytochemistry, Chromatin, Nuclear protein, Intracytoplasmic sperm injection and Monoclonal antibody in his study of Molecular biology.
His most cited work include:
- Fibrous sheath of mammalian spermatozoa. (278 citations)
- The putative chaperone calmegin is required for sperm fertility (243 citations)
- Lack of acrosome formation in mice lacking a Golgi protein, GOPC. (205 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Cell biology, Sperm, Acrosome, Molecular biology and Spermatogenesis.
His Cell biology study deals with Sertoli cell intersecting with Germ cell.
His Sperm study frequently draws parallels with other fields, such as Human fertilization.
Kiyotaka Toshimori has researched Acrosome in several fields, including Golgi apparatus, Vesicle, Acrosome reaction and Spermiogenesis.
As part of one scientific family, Kiyotaka Toshimori deals mainly with the area of Molecular biology, narrowing it down to issues related to the Antigen, and often Immunostaining.
The various areas that Kiyotaka Toshimori examines in his Spermatogenesis study include Genetics, Cytoplasm and Male infertility.
He most often published in these fields:
- Cell biology (48.44%)
- Sperm (35.42%)
- Acrosome (26.56%)
What were the highlights of his more recent work (between 2012-2020)?
- Cell biology (48.44%)
- Sperm (35.42%)
- Acrosome (26.56%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cell biology, Sperm, Acrosome, Spermatogenesis and Male infertility.
His Cell biology study incorporates themes from Gene knockout, Histone and Lipid bilayer fusion.
His Sperm study is associated with Andrology.
The study incorporates disciplines such as Golgi apparatus, Vesicle, Acrosome reaction and Exocytosis in addition to Acrosome.
His Spermatogenesis research is multidisciplinary, incorporating perspectives in Regulator, Molecular biology, Monocarboxylate transporter and Intraflagellar transport.
His Male infertility research includes elements of Phenotype, Epididymis, Sperm motility and Cilium.
Between 2012 and 2020, his most popular works were:
- A mutation of COX6A1 causes a recessive axonal or mixed form of Charcot-Marie-Tooth disease. (48 citations)
- A heterozygous mutation of GALNTL5 affects male infertility with impairment of sperm motility (46 citations)
- Suppression of T Cell Autophagy Results in Decreased Viability and Function of T Cells Through Accelerated Apoptosis in a Murine Sepsis Model (28 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- DNA
His primary areas of study are Cell biology, Apoptosis, Autophagy, Acrosome and Asthenozoospermia.
His Cell biology research includes themes of Biochemistry, Spermatid and ACOX1.
His Acrosome research incorporates elements of Exocytosis, Vesicle, Monomeric Clathrin Assembly Proteins, Clathrin and Golgi apparatus.
His Asthenozoospermia research incorporates themes from Sperm, Andrology, Sperm motility and Oligospermia.
He has included themes like Spermiogenesis and Spermatogenesis in his Male infertility study.
Spermatogenesis and Molecular biology are frequently intertwined in his study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
